TGR5 deficiency activates antitumor immunity in non-small cell lung cancer via restraining M2 macrophage polarization

MLA

Lifang Zhao, et al. “TGR5 Deficiency Activates Antitumor Immunity in Non-Small Cell Lung Cancer via Restraining M2 Macrophage Polarization.” Acta Pharmaceutica Sinica B, vol. 12, no. 2, Feb. 2022, pp. 787–800. EBSCOhost, https://doi.org/10.1016/j.apsb.2021.07.011.

APA

Lifang Zhao, Hongyan Zhang, Xueqing Liu, Shan Xue, Dongfang Chen, Jing Zou, & Handong Jiang. (2022). TGR5 deficiency activates antitumor immunity in non-small cell lung cancer via restraining M2 macrophage polarization. Acta Pharmaceutica Sinica B, 12(2), 787–800. https://doi.org/10.1016/j.apsb.2021.07.011

Chicago

Lifang Zhao, Hongyan Zhang, Xueqing Liu, Shan Xue, Dongfang Chen, Jing Zou, and Handong Jiang. 2022. “TGR5 Deficiency Activates Antitumor Immunity in Non-Small Cell Lung Cancer via Restraining M2 Macrophage Polarization.” Acta Pharmaceutica Sinica B 12 (2): 787–800. doi:10.1016/j.apsb.2021.07.011.